Coronavirus Update: Ex-GSK Exec To Lead Trump's Operation Warp Speed
Moncef Slaoui Confident Of 2020 Goal
US government will fund 'at risk' manufacturing of lead vaccine candidates, with Trump promising US will get priority. But skeptics say year-end timeline is unrealistic.
You may also be interested in...
Plus: Eli Lilly extends its presence in COVID-19 research with an alliance with China's Junshi Biosciences.
Having kept out of the race to develop a vaccine until now, Novartis has joined efforts with a collaboration using the AAV gene therapy vector.
Multiple vaccine and drug developers across the world report progress and partnerships amid volatility in their shares.